Market Research Logo

Global Influenza Vaccine Market 2018-2022

Global Influenza Vaccine Market 2018-2022

About Influenza Vaccine

Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes moderate to severe illness, while the infection due to influenza B virus results in milder disease and affects pediatrics primarily. Human illness due to influenza C is rare. Influenza C illness might be due to subclinical cases. Hence, it does not cause epidemic diseases. Influenza has emerged as a severe health concern globally. The market encompasses both live attenuated as well as recombinant influenza vaccines for the prevention of influenza. The major factors that lead to the market growth include the need for annual vaccination and government initiatives to improve awareness about vaccination.

Technavio’s analysts forecast the global influenza vaccine market to grow at a CAGR of 7.23% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global influenza vaccine market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of influenza vaccine.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Influenza Vaccine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AstraZeneca
  • CSL
  • GlaxoSmithKline
  • Sanofi
Other prominent vendors
  • Altimmune
  • BionVax
  • FluGen
  • FOLIA BIOTECH
  • Genentech
  • Green Cross
  • Medicago
  • Moderna Therapeutics
  • Novavax
  • Shijiazhuang Yiling Pharmaceutical
  • SK Chemicals
  • UNM Pharma
  • Vaccitech
  • Vaxart
  • Vaxine Pty
  • Visterra.
Market driver
  • Rising awareness about influenza vaccination
  • For a full, detailed list, view our report
Market trend
  • Development of strong pipeline
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Influenza Vaccine Market 2018-2022

Technavio recognizes the following companies as the key players in the global influenza vaccine market: AstraZeneca, CSL, GlaxoSmithKline, and Sanofi.

Other Prominent Vendors in the market are: Altimmune, BionVax, FluGen, FOLIA BIOTECH, Genentech, Green Cross, Medicago, Moderna Therapeutics, Novavax, Shijiazhuang Yiling Pharmaceutical, SK Chemicals, UNM Pharma, Vaccitech, Vaxart, Vaxine Pty, and Visterra.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is development of strong pipeline. The increasing R&D programs is significantly influencing the growth of the pipeline molecule count in the influenza market. Universal influenza vaccine initiative (UIVI) is a program conducted to combat the challenges in developing a vaccine that broadly protects against all types of influenza viruses. Furthermore, the number of clinical trials for developing a vaccvine for treating influenza is steadily increasing. The launch of all molecules in phase III will generate significant revenue on completion of the clinical trials.”

According to the report, one of the major drivers for this market is rising awareness about influenza vaccination. With the growing support of both government and non-government bodies, the awareness about influenza virus is rising across the globe. Both the government and non-government organizations are taking adequate initiatives to prevent diseases. To educate people about the influenza virus and the importance of influenza vaccination, CDC conducts national vaccination week. WHO has developed generic campaign materials to support the campaign. Such initiatives will help people gain more knowledge about the preventive measures available against influenza, in turn, driving the demand for these vaccines.

Companies Mentioned

AstraZeneca, CSL, GlaxoSmithKline, Sanofi, Altimmune, BionVax, FluGen, FOLIA BIOTECH, Genentech, Green Cross, Medicago, Moderna Therapeutics, Novavax, Shijiazhuang Yiling Pharmaceutical, SK Chemicals, UNM Pharma, Vaccitech, Vaxart, Vaxine Pty, and Visterra.

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global vaccine market: Segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition: Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global influenza vaccine market 2017-2022 ($ millions)
      • Table Global influenza vaccine market: Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition: Five forces 2017
  • Pipeline landscape
    • Table Pipeline landscape by development phase
    • Table Key clinical trials candidates of influenza vaccines
  • Market segmentation by vaccine type
    • Overview
      • Table Global influenza vaccine market by vaccine type 2017-2022 (%)
    • Comparison by vaccine type
      • Table Comparison by vaccine type
    • Global live attenuated influenza vaccines market
      • Table Global live attenuated influenza vaccines market 2017-2022 ($ millions)
      • Table Global live attenuated influenza vaccines market: Year-over-year growth 2018-2022 (%)
    • Global recombinant influenza vaccines market
      • Table Global recombinant influenza vaccines market 2017-2022 ($ millions)
      • Table Global recombinant influenza vaccines market: Year-over-year growth 2018-2022 (%)
    • Market opportunity by vaccine type
      • Table Market opportunity by vaccine type
  • Market segmentation by age group
    • Adults
      • Table Adult influenza vaccine products and their cost
    • Pediatrics
      • Table Pediatric influenza vaccine products and their cost
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global influenza vaccine market by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Influenza vaccine market in Americas
      • Table Influenza vaccine market in Americas 2017-2022 ($ millions)
      • Table Influenza vaccine market in Americas: Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • Influenza vaccine market in EMEA
      • Table Influenza vaccine market in EMEA 2017-2022 ($ millions)
      • Table Influenza vaccine market in EMEA: Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • Influenza vaccine market in APAC
      • Table Influenza vaccine market in APAC 2017-2022 ($ millions)
      • Table Influenza vaccine market in APAC: Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Distribution of influenza vaccine doses in US by season
    • Market challenges
      • Table Steps for production of IIV
  • Market trends
    • Strong pipeline
      • Table Molecules in phase III with sponsors
    • Strategic alliances
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Overview
      • Table Vendor landscape
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AstraZeneca
      • Table AstraZeneca: Overview
      • Table AstraZeneca: Business segments
      • Table AstraZeneca: Organizational developments
      • Table AstraZeneca: Geographic focus
      • Table AstraZeneca: Segment focus
      • Table AstraZeneca: Key offerings
      • Table AstraZeneca: Key customers
    • CSL
      • Table CSL: Overview
      • Table CSL: Business segments
      • Table CSL: Organizational developments
      • Table CSL: Geographic focus
      • Table CSL: Segment focus
      • Table CSL: Key offerings
      • Table CSL: Key customers
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Overview
      • Table GlaxoSmithKline: Business segments
      • Table GlaxoSmithKline: Organizational developments
      • Table GlaxoSmithKline: Geographic focus
      • Table GlaxoSmithKline: Segment focus
      • Table GlaxoSmithKline: Key offerings
      • Table GlaxoSmithKline: Key customers
    • Sanofi
      • Table Sanofi: Overview
      • Table Sanofi: Business segments
      • Table Sanofi: Organizational developments
      • Table Sanofi: Geographic focus
      • Table Sanofi: Segment focus
      • Table Sanofi: Key offerings
      • Table Sanofi: Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report